Inventor · Branford, CT, US

Akihiro Hashimoto

70Patents
20h-index
31Co-inventors
88Inventor score

Filing activity: Mar 6, 2001 → Jan 22, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US9598446B2 Amino compounds for treatment of complement mediated disorders Chemistry; Metallurgy 24 Active
US9695205B2 Amide compounds for treatment of complement mediated disorders Chemistry; Metallurgy 24 Active
US9796741B2 Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders Chemistry; Metallurgy 24 Active
US9663543B2 Phosphonate compounds for treatment of complement mediated disorders Chemistry; Metallurgy 24 Active
US10138225B2 Amide compounds for treatment of medical disorders Chemistry; Metallurgy 23 Active
US10550140B2 Ether compounds for treatment of complement mediated disorders Chemistry; Metallurgy 23 Active
US9732103B2 Carbamate, ester, and ketone compounds for treatment of complement mediated disorders Chemistry; Metallurgy 22 Active
US10106563B2 Ether compounds for treatment of complement mediated disorders Chemistry; Metallurgy 22 Active
US9732104B2 Ether compounds for treatment of complement mediated disorders Chemistry; Metallurgy 22 Active
US10370394B2 Carbamate, ester, and ketone compounds for treatment of complement mediated disorders Chemistry; Metallurgy 21 Active
US10081645B2 Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders Chemistry; Metallurgy 21 Active
US10385097B2 Ether compounds for treatment of medical disorders Chemistry; Metallurgy 21 Active
US10189869B2 Amino compounds for treatment of complement mediated disorders Chemistry; Metallurgy 21 Active
US10287301B2 Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders Emerging Cross-Sectional Technologies 21 Active
US10100072B2 Phosphonate compounds for treatment of complement mediated disorders Chemistry; Metallurgy 21 Active
US10011612B2 Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders Emerging Cross-Sectional Technologies 21 Active
US9828396B2 Alkyne compounds for treatment of complement mediated disorders Chemistry; Metallurgy 21 Active
US10301336B2 Phosphonate compounds for treatment of complement mediated disorders Chemistry; Metallurgy 21 Active
US10000516B2 Phosphonate compounds for treatment of medical disorders Chemistry; Metallurgy 21 Active
US10005802B2 Amide compounds for treatment of complement mediated disorders Chemistry; Metallurgy 21 Active
US10428094B2 Amide compounds for treatment of complement mediated disorders Chemistry; Metallurgy 20 Active
US10253053B2 Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders Chemistry; Metallurgy 20 Active
US10464956B2 Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders Chemistry; Metallurgy 20 Active
US10092584B2 Compounds for the treatment of medical disorders Human Necessities 20 Active
US10087203B2 Compounds for treatment of complement mediated disorders Chemistry; Metallurgy 20 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.